Stan Berenshteyn
Stock Analyst at Wells Fargo
(0.88)
# 3,999
Out of 5,004 analysts
309
Total ratings
48.1%
Success rate
-1.8%
Average return
Main Sectors:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Reiterated: Buy | $125 | $88.25 | +41.64% | 59 | Sep 25, 2026 | |
| VEEV Veeva Systems | Reiterated: Buy | $330 | $280.68 | +17.57% | 45 | Sep 23, 2026 | |
| OMDA Omada Health | Reiterated: Hold | $18 → $22 | $19.66 | +11.90% | 5 | Sep 14, 2026 | |
| PHR Phreesia | Rated: Hold | $9 → $10 | $10.15 | -1.48% | 7 | Sep 3, 2026 | |
| PGNY Progyny | Initiated Coverage: Buy | $37 | $25.44 | +45.44% | 1 | Aug 20, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $33 | $24.70 | +33.60% | 4 | Aug 19, 2026 | |
| HCAT Health Catalyst | Rated: Hold | $1.75 → $1.5 | $1.74 | -13.79% | 27 | Aug 13, 2026 | |
| CTEV Claritev | Reiterated: Hold | $22 → $30 | $23.20 | +29.31% | 4 | Aug 12, 2026 | |
| DOCS Doximity | Downgraded: Sell | $18 | $26.35 | -31.69% | 34 | Aug 10, 2026 | |
| AMWL American Well | Reiterated: Buy | $16 | $13.43 | +19.14% | 18 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $55 → $50 | $33.66 | +48.54% | 55 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $6.09 | -1.48% | 9 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $90 | $95.57 | -5.83% | 5 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $3.35 | +4.48% | 35 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $17.81 | n/a | 1 | Oct 6, 2015 |
HealthEquity
Sep 25, 2026
Reiterated: Buy
Price Target: $125
Current: $88.25
Upside: +41.64%
Veeva Systems
Sep 23, 2026
Reiterated: Buy
Price Target: $330
Current: $280.68
Upside: +17.57%
Omada Health
Sep 14, 2026
Reiterated: Hold
Price Target: $18 → $22
Current: $19.66
Upside: +11.90%
Phreesia
Sep 3, 2026
Rated: Hold
Price Target: $9 → $10
Current: $10.15
Upside: -1.48%
Progyny
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $25.44
Upside: +45.44%
Waystar Holding
Aug 19, 2026
Reiterated: Buy
Price Target: $33
Current: $24.70
Upside: +33.60%
Health Catalyst
Aug 13, 2026
Rated: Hold
Price Target: $1.75 → $1.5
Current: $1.74
Upside: -13.79%
Claritev
Aug 12, 2026
Reiterated: Hold
Price Target: $22 → $30
Current: $23.20
Upside: +29.31%
Doximity
Aug 10, 2026
Downgraded: Sell
Price Target: $18
Current: $26.35
Upside: -31.69%
American Well
Aug 5, 2026
Reiterated: Buy
Price Target: $16
Current: $13.43
Upside: +19.14%
Jul 30, 2026
Rated: Buy
Price Target: $55 → $50
Current: $33.66
Upside: +48.54%
Jul 30, 2026
Reiterated: Hold
Price Target: $6
Current: $6.09
Upside: -1.48%
Jun 24, 2026
Rated: Buy
Price Target: $80 → $90
Current: $95.57
Upside: -5.83%
Jun 2, 2026
Reiterated: Buy
Price Target: $3.5
Current: $3.35
Upside: +4.48%
Oct 6, 2015
Initiated Coverage: Buy
Price Target: $34
Current: $17.81
Upside: n/a